Where does CTI vascular AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CTI vascular AG ranks #34,896 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CTI vascular AG hold?

CTI vascular AG holds 7 US utility patents granted between 2020 and 2025, spanning 3 technology areas.

What is CTI vascular AG's Innovation Score?

CTI vascular AG has an Innovation Score of 27.6 out of 100 (24th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is CTI vascular AG's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for CTI vascular AG.

What does claim depth mean for CTI vascular AG's patents?

CTI vascular AG's patents average 18.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CTI vascular AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

CTI vascular AG

Q: What technology areas does CTI vascular AG focus on?

CTI vascular AG's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 6 patents. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, CTI ranks #34,896 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 3 technology areas.

#34,896
of 49,997 US assignees by volume: 24th percentile
by Innovation Score (27.6/100): 18.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R34896 · Foreign Corporation #34,896 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #34,896/49,997
PHOTO-FINISH Cscm Management
CPC-NARROW A61M · 3 areas
INNOV-THIN 27.6/100
CLAIMS-RICH 18.3 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Cscm Management Company LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Amag Rolling · near

28
Advanced Processor… · near

28
CTI vascular · this assignee

28
DWFritz Automation · near

28
Sophono · near

28
3D Lighting… · lowest

7

What this shows CTI's Innovation Score is 27.6/100 (24th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where CTI's grants concentrate

CTI vascular AG is a focused PatentsView assignee: 3 CPC subclasses with 85.7% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2021. By volume, CTI sits between Cscm Management Company LLC and Curtiss-wright Flow Control Corporation.

CTI's three-year grant acceleration

CTI vascular AG shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cscm Management

7
Cstone Pharmaceut…

7
Cstone Pharmaceut…

7
CTC Global

7
Ctrl IQ

7
Curioxr

7
Curtin University…

7
Curtiss-wright Fl…

7
CTI vascular ◀

7

What this shows CTI holds 7 patents at rank #34,745, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CTI

By rank, the assignees closest to #34,745 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in CTI's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for CTI, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (28 here).

DWFritz Automation, LLC 28 Advanced Processor Architectures, LLC 28 Sophono, Inc. 28 Amag Rolling Gmbh 28

CTI's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 24th percentile higher than 24% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

CTI vascular AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	3	42.9%
2021	1	14.3%
2024	2	28.6%
2025partial year	1	14.3%

Which technologies does CTI vascular AG patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

A61B - DIAGNOSIS; SURGERY; Identification 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

Top 3 of 3 technology areas

Where it ranks

Overall rank by patents

#34,896

of 49,997 tracked assignees

Innovation Score

27.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

CTI vascular AG's patent record in context - here's where to go next.

CTI vascular AG's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 85.7% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #34,896 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CTI vascular AG against Cscm Management Company LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.